Skip to main content

NEOG Neogen Corporation

Healthcare

11.71

Close 10/8

Open
11.50
High
12.21
Low
11.13
Prev close
11.68
Volume
8.7M
P/B
1.2
52W 5.37 14.26
Loading candles…

Is Neogen Corporation a buy? Fundamentals and valuation first

As of 2026-10-08

Valuation: Fair, Momentum: Strong.

Valuation Fair Price / book is Fair; Free-cash-flow yield is Good.
TTM P/E -46.25 N/A
Price / book 1.23 42th percentile Fair
Free-cash-flow yield (%) 1.95 53th percentile Good
Quality Neutral FCF margin, TTM is Good, but Operating margin, TTM is Average.
ROE, TTM (%) -2.69 36th percentile Average
Operating margin, TTM (%) -0.83 34th percentile Average
FCF margin, TTM (%) 5.63 53th percentile Good
Growth Neutral All 2 indicators are Average.
Revenue growth, TTM YoY (%) -0.33 34th percentile Average
Diluted EPS growth, TTM YoY (%) -94.73 22th percentile Average
Momentum Strong All 2 indicators are Top.
60-day return (%) 17.33 89th percentile Top
240-day return (%) 92.92 94th percentile Top
Risk / liquidity Neutral 20-day dollar volume is Top, but 60-day annualized volatility is Pricey.
20-day dollar volume 70,045,904 84th percentile Top
60-day annualized volatility (%) 62.57 65th percentile Pricey

Neogen Corporation (NEOG) today

1 quant signals active · As of 2026-10-08

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

Neogen Corporation (NEOG) peers and tracking

Watchlist

This page refreshes daily after the close. Add Neogen Corporation to your watchlist to track signal changes on your next visit.

Neogen Corporation (NEOG) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

EPS surprise beat

Active · now 50.01%

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

16 historical occurrences (since 2016-12-21)
Average forward return after EPS surprise beat。20-day: Win 46.7%, Sample 15, Median -1.32%, Excess -3.19%, Beat mkt rate 33.3%；60-day: Win 50%, Sample 14, Median +1.13%, Excess -8.02%, Beat mkt rate 42.9%；120-day: Win 64.3%, Sample 14, Median +6.48%, Excess -4.3%, Beat mkt rate 35.7%

120 days after: historical avg +3.97%

20-day -0.15%
60-day -5.26%
120-day +3.97%
20-day
60-day
120-day
Win
46.7%
50%
64.3%
Sample
15
14
14
Median
-1.32%
+1.13%
+6.48%
Excess
-3.19%
-8.02%
-4.3%
Beat mkt rate
33.3%
42.9%
35.7%

Over 14 occurrences, 120-day forward avg gained 3.97%, lagged the market by 4.3 pts; win rate 64.3%.

More history: Market-wide momentum baseline, Signals not active now

Market-wide momentum baseline

Across 98,247 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.22%, a 57.8% positive-return rate, and +2.87 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

14 times historically; 60-day forward avg -1.18%, win rate 50%, beating the market by -5.03 pts on average.

Top-quintile 6-month momentum

Pending

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

15 times historically; 60-day forward avg +6.35%, win rate 71.4%, beating the market by +2.02 pts on average.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

8 times historically; 60-day forward avg -1.18%, win rate 62.5%, beating the market by -5.86 pts on average.

Continue researching Neogen Corporation with the evidence above.

Continue in Studio ↗

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.